# Moderna, Inc. (MRNA) is a biotechnology company that provides messenger RNA medicines.

*biotech · news · 2026-05-06 · Barchart*

## Key points

- Moderna's revenue surged 260% year-over-year to $389 million due to international contracts.
- Despite Q1 revenue beat, MRNA shares dropped 1.2% due to a litigation settlement charge.
- Analysts expect Moderna's loss per share to increase by 9.5% to $7.95 this fiscal year.
- Moderna is trading above its mean price target, but upside potential exists up to $135 per share.

**Companies:** Moderna, Inc.
**Countries:** United Kingdom

[Read the full story on Barchart](https://www.barchart.com/story/news/1756480/is-wall-street-bullish-or-bearish-on-moderna-stock)

---

Canonical: https://newsio.io/n/1fa3b482-1d7c-43d1-b25f-727b017d2c47/moderna-inc-mrna-is-a-biotechnology-company-that-provides-messenger-rna-medicine
Summarized by Newsio from Barchart. https://newsio.io/how-it-works